Perspective Therapeutics (CATX.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov11

BTIG Analyst Maintains Buy Rating on Perspective Therapeutics

12:43

Perspective Therapeutics released FY2025 Q3 earnings on November 10 After-Market EST, actual revenue USD 209K (forecast USD 206.84K), actual EPS USD -0.3495 (forecast USD -0.3244)

00:00

Perspective Therapeutics released FY2025 9 Months earnings on November 10 After-Market EST, actual revenue USD 841K, actual EPS USD -0.8901

00:00

Nov3

Perspective Therapeutics to Release FY2025 Q3 Earnings on November 10 After-Market EST, Forecast Revenue USD 206.84 K, EPS USD -0.3244

00:12

Oct8

Jones continues to favor Perspective Therapeutics

12:31

Oct3

Robert Burns Gives Perspective Therapeutics a Buy Rating

10:41

Schedules & Filings

Schedules

Filings

Nov10

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 209 K, Net Income -25.97 M, EPS -0.3495

Aug13

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 290 K, Net Income -21.49 M, EPS -0.2894

May12

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 342 K, Net Income -18.18 M, EPS -0.2512

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change